Internal Medicine, Medical Oncology · Ypsilanti, MI
NPI
1568666535
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5303 Elliott Dr
Ypsilanti, MI, 48197
Phone (734) 712-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,231 services
Medicare patients, 2024
367
Average age 75
Drug cost, 2024
$4.4M
2,025 prescriptions
Company payments, 2025
$98.47
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Li Ding was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 355 times for 196 patients. In total Li Ding billed 1,231 services in 23 codes, and Medicare paid $76K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 355 | 196 | $12.80 | $4,545 |
| 99214 Office E&M - Established | Office | 334 | 165 | $93.28 | $31K |
| 99213 Office E&M - Established | Office | 146 | 124 | $63.69 | $9,299 |
| 99222 Hospital E&M - Initial | Facility | 68 | 65 | $104.75 | $7,123 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 63 | 15 | $73.73 | $4,645 |
| 99215 Office E&M - Established | Office | 56 | 42 | $139.89 | $7,834 |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 37 | $63.03 | $2,963 |
| 99204 Office E&M - New | Office | 15 | 15 | $134.91 | $2,024 |
| 99442 Telephone Services | Office | 14 | 14 | $63.18 | $885 |
| 99233 Hospital E&M - Subsequent | Facility | 12 | 11 | $94.69 | $1,136 |
By year: 2022 $111K for 1,065 services; 2023 $89K for 1,017 services; 2024 $76K for 1,231 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 12 | $7.84 | $110 |
Medicare prescription drug claims, 2024
In 2024, the drug Li Ding prescribed most often to Medicare patients was Anastrozole, with 379 prescriptions and refills. In total Li Ding wrote 2,025 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 379 | 898 | 101 | $17K |
| Tamoxifen Citrate Generic | 119 | 285 | 31 | $3,999 |
| Prochlorperazine Maleate Generic | 110 | 112 | 59 | $2,299 |
| Exemestane Generic | 100 | 286 | 33 | $30K |
| Letrozole Generic | 96 | 231 | 28 | $5,224 |
| Prednisone Generic | 72 | 76 | 15 | $333 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 23 | $691 |
| Dexamethasone Generic | 67 | 85 | 40 | $1,131 |
| Eliquis Apixaban | 66 | 96 | 18 | $52K |
| Ibrance Palbociclib | 51 | 51 | Under 11 | $746K |
| Acyclovir Generic | 51 | 89 | 14 | $1,100 |
| Calquence Acalabrutinib Maleate | 48 | 48 | Under 11 | $627K |
| Hydroxyurea Generic | 42 | 89 | Under 11 | $1,594 |
| Abiraterone Acetate Generic | 38 | 38 | Under 11 | $46K |
| Revlimid Lenalidomide | 37 | 37 | Under 11 | $742K |
Brand drugs: - claims; generic drugs: 1,624 claims; opioid claims: 152.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Li Ding $98.47 ($98.47 in general payments such as food, travel and fees) from 1 company. The largest payer was Tempus AI, Inc with $98.47.
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc TEM | 1 | $98.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.